Allington, Douglas

Beall, Donna G.

Bradley, Lee Ann

Hudgins, Gayle A.

Keeley, Kendra

Macklin, Rose

Madson, Kim

Miller, Sarah

Rivey, Michael P.

English

University of Montana

University of Montana ScholarWorks at University of Montana University of Montana Course Syllabi Open Educational Resources (OER) Fall 9-1-2008 PHAR 553.00: Therapeutics III Michael P. Rivey University of Montana, Missoula, michael.rivey@umontana.edu Douglas Allington University of Montana, Missoula, douglas.allington@umontana.edu Rose Macklin University of Montana, Missoula, rose.macklin@umontana.edu Lee Ann Bradley University of Montana, Missoula Sarah Miller University of Montana, Missoula, sarah.miller@umontana.edu See next page for additional authors Follow this and additional works at: https://scholarworks.umt.edu/syllabi Let us know how access to this document benefits you. Recommended Citation Rivey, Michael P.; Allington, Douglas; Macklin, Rose; Bradley, Lee Ann; Miller, Sarah; Hudgins, Gayle A.; Beall, Donna G.; Madson, Kim; and Keeley, Kendra, "PHAR 553.00: Therapeutics III" (2008). University of Montana Course Syllabi. 11971. https://scholarworks.umt.edu/syllabi/11971 This Syllabus is brought to you for free and open access by the Open Educational Resources (OER) at ScholarWorks at University of Montana. It has been accepted for inclusion in University of Montana Course Syllabi by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact scholarworks@mso.umt.edu. Instructor Michael P. Rivey, Douglas Allington, Rose Macklin, Lee Ann Bradley, Sarah Miller, Gayle A. Hudgins, Donna G. Beall, Kim Madson, and Kendra Keeley This syllabus is available at ScholarWorks at University of Montana: https://scholarworks.umt.edu/syllabi/11971                                        Pharmacy 553 Therapeutics III:  Fall 2008 Lectures:   Tuesday & Thursday 9:10-11:00  SB 117 Course Coordinator: Michael Rivey  ====>  M. Rivey Instructors:   Douglas Allington         Office:  243-6796    Rose Macklin      Community Hosp: 327-4299    Lee Ann Bradley                 ext. 7605    Sarah Miller               Pager: 329-6122    Gayle Hudgins   Home: 251-3369    Donna Beall    Cell: 546-5534    Kim Madson    Kendra Keeley      Material and Resources Required Texts: DiPiro Pharmacotherapy, 6th  edition APhA:  Handbook of Nonprescription Drugs 15th  edition Medical Letter on Drugs & Therapeutics Goodman & Gilman's Pharmacological Basis of Therapeutics A medical dictionary Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text             Optional Texts: Murphy: Clinical Pharmacokinetics pocket reference    Boh Pharmacy Practice Manual    Evans:  Applied Pharmacokinetics    Young, Koda-Kimble:  Applied Therapeutics    Herfindal, Gourley, Hart:  Clinical Pharmacy and Therapeutics    Hansten & Horn:  Drug Interactions           Goals of the CourseTo promote the students' understanding of common disease states with particular emphasis on the facets of diseases that are amenable to drug therapy. To familiarize the student with the proper use of drugs in a clinical setting.  To develop the students' awareness of factors that should be considered prior to selection of a drug and the appropriate parameters that should be monitored for therapeutic as well as undesired effects. To encourage the students' ability to problem-solve in the clinical setting.                                                          2 Performance ObjectivesUpon completion of this course, each student shall be able to:Relate the pathophysiology of a disease to the known or purported action of a drug.Evaluate the seriousness of a disorder based on the signs and symptoms related to adiagnosed problem, and:--determine the necessity of drug therapy,--when applicable, choose the proper drug and/ordrug product for the situation.Determine the place of non-pharmacologic and natural therapies, when applicable.Tailor the drug therapy of an individual based on patient characteristics and known pharmacokinetics principles.Identify potential drug-drug interactions.Monitor the appropriate parameters of a disease to determine if the patient is respondingpositively to therapy.Monitor for adverse drug reactions and exacerbations of underlying patient problemsresulting from drug therapy.Student Responsibilities and Obligations*To attend and participate in lecture sessions.*To do assigned readings from the texts.*To attend Integrated Studies conferences, prepare each case in advance, to present a patient case, and participate in the discussion of all patient presentations.*To perform satisfactorily on course quizzes and lecture examinations.                                                                                                                                                 3 GRADING IN COURSE:  Phar 553 Therapeutics III3 midterm exams: 100 points eachFinal exam (comprehensive, multiple choice)(80 pts comprehensive, 50 pts over new topic lectures)Topic quizzes:  8 quizzes graded on 10 pts eachTOTAL POINTS FOR COURSE300 points130 pointsBonus pts > 75% (60 pts)430 POINTSClass quizzes: The purposes of the quizzes are to promote reading of the text before a topicand encourage class attendance and attention.  Quizzes will occur before topic lectures and willtest understanding of basic concepts in the reading assignment, and will cover onlychapter/reading material associated with the day the quiz is scheduled. If there are multiple chapters or readings, the one for quiz content is indicated.A quiz will consist of 5 multiple choice or true/false questions, each worth 2 points. QUIZ on syllabus indicates a quiz will be given for assigned reading at start of the given lecture.  Lowest2 quiz grades will be thrown out; no make-ups will be allowed for quiz. Scoring: Quizperformance can only benefit student; bonus points for the course will be awarded for allpoints over 75% (i.e. 60 pts) of the potential total 80 pts on the quizzes (10 total quizzes – 2 throw-outs = 8x10 pts)Exams: 3 midterm exams:  Tests will be in "traditional" case report fashion with multiple choice/shortanswers required.  Tests will be given on Thursday late afternoons 4:30-6:30 PM. Work is not an acceptable excuse for not taking a test during the test time.  Any excusefor missing a test must be approved BEFORE the test is given, and an Agreement fortaking the test at an alternate time will be filed in the Dean’s Office.  Calculators may be required for tests; PDAs are not allowed.Final exam:  65 multiple choice questions worth 2 pts each.  An effort will be made to design questions in the style similar to what you will encounter on the NAPLEX exam.Grading: Grades generally follow closely to 90-100% A; 80-89% B; 70-79% C; 60-69% D, and below 60%F.  Grades may be slightly given on a curve depending on overall students’ performance in course.  We do use the +/- system for gradingUM Statement All students must practice academic honesty.  Academic misconduct is subject to an academicpenalty by the course instructor and/or disciplinary sanction by the UniversityAll students need to be familiar with the Student Conduct Code.  The Code is available forreview online at http://www.umt.edu/SA/VPSA/index.cfm/page/1321                                                                                    4 Integrated Studies Conferences: you will be assigned to a conference based on period you registered for; instructors are not necessarily the ones under which you registered.Attendance/make-up is required for all topics/cases; you may attend a different conference in order to complete the assignment, but ONLY with instructor permission.  The “make-up”requirement for a conference missed due to unavoidable incident will be at the discretion of theinstructor, dependent on the topic.  Failure to complete any conference will result in a grade of“fail” for course.Class civility: Your student colleagues have strongly indicated to us that they wish to spend their valuable time in class listening to the therapeutics topics.  They do not appreciate any“side” conversations while the instructor is lecturing.  They do appreciate students raisingquestions about important lecture aspects for further discussion or clarification.Out of respect for your classmates, we will not tolerate excessive and disruptive talkingduring lecture.  The instructor may first ask you to be silent; you may be asked to leave class ifyou persist in disruptive talking.  The instructor will be the judge of “what” constitutesdisruption. Please note that we encourage questions and relevant discussion.Cell phones must be in the “off” mode during class.  Disruption due to the use of cell phonesin class will not be tolerated; this includes cell phones turned to the “vibration” mode.Policy regarding young children: It may sometimes be necessary for a student to bring theiryoung child to class, due to school illness policy, daycare provider illness, or off-school days.  Itis acceptable to bring a child to class ONLY in those situations. Do not bring an acutely ill child to class. Please remember that children generally are NOT entertained by a therapeuticslecture, so provide some activity for them during class.It is the responsibility of the parent to assure that the child does not disrupt other students.Reading assignments: Reading assignments as listed in the syllabus are for DiPiro 6th edition and the Handbook of Nonprescription Drugs 15th edition.* NOTE: the DiPiro 6th edition was released in summer 2005. Material contained in a textbook typically is over 1 year old by the time the edition is printed. Please note that whendiscrepancies arise between what the professor presents in lecture and what is contained in thetextbook, the content provided in class is more current- we strive to present the most currentinformation vs. what is contained in a textbook.                                                                                                                                                                                                                                                                                                                                                                                                   5 Therapeutics 553 Pharm.D.: Lecture SyllabusInstructor ReadingAug 26 T Introduction/ Liver disease MPR 4028 Th Liver disease MPR 37Sept 2 Renal disease/ QUIZ DRA 41, 424 Renal Disease DRA 43, 44, pp 851-619 T Pain management/ QUIZ LAB 6011 Th Headache DGB 59, OTC 516 T Contraception/ QUIZ DGB 77 (quiz), OTC 1018 Th-1 Contraception DGB18 Th-1 Urinary Disorders DRA 83, OTC 5223 T Menopause/ QUIZ GAH 8025 Th Osteoporosis GAH 88, OTC 459-46025 Th Test 1 at 4:30-6:30 PM; through urinary disorders30 T-1 no class, in lieu of test 130 T-2 Arthritis MPR 90, OTC 72-83Oct 2 Th Arthritis/ QUIZ MPR 89 (quiz)7 T-1 Gout MPR 917 T-2 Fluid & electrolytes SJM pp 937-50; 967-769 Th F & E SJM pp 950-63; 976-8014 T Nutrition support/ QUIZ SJM pp 2559-64; 2569-72 ;2591-816 Th Nutrition support SJM pp 2598-2611; 13821 T Oncology/ QUIZ KAM TBA23 Th Oncology KAM23 Th Test 2 at 4:30-6:30 PM; through Nutrition Support28T Oncology KAM30 Th Nausea & Vomiting LAB 35, OTC 20Nov 4 T ELECTION DAY: off (in lieu of test 2)6 Th Asthma KAK 2611 T VETERANS DAY: off (in lieu of test 3)13 Th-1 Respiratory pharmacotherapy KAK 25, OTC 1313 Th-2 COPD/ QUIZ DRA 27553-Ther III, continued                                                                                                                                            6 Instructor ReadingNov 18 T-1 COPD DRA18 T-2 Thromboembolic disease/ QUIZ MPR 1920 Th-1 TED MPR 20 Th-2 Stroke MPR 2020 Th Test 3 at 4:30-6:30 PM ; through COPD25 M * Diabetes mellitus/ QUIZ LRM 7227 Th OFF: THANKSGIVING HOLIDAYDec 2 T Diabetes mellitus LRM OTC 474 Th CLASS EVALUATIONThyroid disease MPR 73Final, Dec 10 at 1010-1200:  test 4, 130 pts comprehensive multiple choice

PHAR 553.00: Therapeutics III

https://scholarworks.umt.edu/cgi/viewcontent.cgi?article=12909&context=syllabi

PHAR 553.00: Therapeutics III

Abstract

Similar works

Full text

Available Versions

University of Montana